RSS   Newsletter   Contact   Advertise with us
Post Online Media

BioTime appoints Jim Knight as senior vice president

BioTimeBioTime, a biotechnology company, announced that it has appointed Jim Knight as senior vice president, head of corporate development.
Article continues below

READ MORE BioTime appoints Lesley Stolz as EVP, corporate development

Mr. Knight brings more than 20 years of experience in creating portfolio value at publicly-traded companies including, Questcor Pharmaceuticals, Inc. and Elan Pharmaceuticals.

Most recently, Mr. Knight was the Vice President of Portfolio Strategy at Questcor from 2010 through 2014. Questcor was acquired by Mallinckrodt Pharmaceuticals and Mr. Knight stayed on for a transition and integration period through 2015.

Prior to Questcor, Mr. Knight was at Elan Pharmaceuticals from 2001 to 2008, where he led a global strategic marketing team, working closely with collaborators at Biogeny.

Mr. Knight started his career in the research group at Biogen, before moving to sales and market analysis roles.

He has a BS in Biology from the University of Massachusetts, Amherst and an MBA in High Technology from Northeastern University.



We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy